79 related articles for article (PubMed ID: 2706512)
1. Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis.
Hamamura T; Kazahaya Y; Otsuki S
Brain Res; 1989 Mar; 483(1):78-83. PubMed ID: 2706512
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
Hirata H; Ogawa N; Asanuma M; Ota Z; Mori A
Brain Res; 1993 Feb; 604(1-2):197-204. PubMed ID: 8457848
[TBL] [Abstract][Full Text] [Related]
3. Regional effects of ceruletide, a cholecystokinin-8 analog, on the striatal monoaminergic systems in food-deprived mice.
Yamada T; Kimura H
Brain Res; 1991 Feb; 540(1-2):25-30. PubMed ID: 1711395
[TBL] [Abstract][Full Text] [Related]
4. Effect of cerulein on in vivo release of acetylcholine from the rat striatum.
Shimoyama M; Kito S
Brain Res; 1989 Jul; 492(1-2):381-4. PubMed ID: 2752307
[TBL] [Abstract][Full Text] [Related]
5. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
Hagino Y; Moroji T
Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats.
Ibii N; Ikeda M; Takahara Y; Eigyo M; Akiyoshi T; Matsushita A
Peptides; 1989; 10(4):779-83. PubMed ID: 2587420
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
Kihara T; Ikeda M; Matsubara K; Matsushita A
Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
[TBL] [Abstract][Full Text] [Related]
8. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats.
Chapman CD; Gazzara RA; Howard SG
Neuropharmacology; 1990 Apr; 29(4):319-25. PubMed ID: 2342635
[TBL] [Abstract][Full Text] [Related]
9. Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
Kihara T; Ikeda M; Ibii N; Matsushita A
Brain Res; 1992 Aug; 588(2):270-6. PubMed ID: 1393578
[TBL] [Abstract][Full Text] [Related]
10. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Walters DE; Chapman CD; Howard SG
J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
[TBL] [Abstract][Full Text] [Related]
11. Effect of systemically administered caerulein on dopamine metabolism in rat brain.
Matsumoto T; Nakahara T; Uchimura H; Hirano M; Yokoo H; Nakamura K; Oomagari K
Brain Res; 1984 Dec; 324(1):195-9. PubMed ID: 6518389
[TBL] [Abstract][Full Text] [Related]
12. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
Kihara T; Ikeda M; Matsushita A
Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
[TBL] [Abstract][Full Text] [Related]
13. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
[TBL] [Abstract][Full Text] [Related]
14. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
Kito S; Shimoyama M; Arakawa R
Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
[TBL] [Abstract][Full Text] [Related]
15. Phenylalanine administration influences dopamine release in the rat's corpus striatum.
During MJ; Acworth IN; Wurtman RJ
Neurosci Lett; 1988 Oct; 93(1):91-5. PubMed ID: 3211373
[TBL] [Abstract][Full Text] [Related]
16. Influence of potassium concentration in microdialysis perfusate on basal and stimulated striatal dopamine release: effect of ceruletide, a cholecystokinin-related peptide.
Kihara T; Ikeda M; Miyazaki H; Matsushita A
J Neurochem; 1993 Nov; 61(5):1859-64. PubMed ID: 8228999
[TBL] [Abstract][Full Text] [Related]
17. Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis.
Akimoto K; Hamamura T; Otsuki S
Brain Res; 1989 Jun; 490(2):339-44. PubMed ID: 2765867
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
Santiago M; Rollema H; de Vries JB; Westerink BH
Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
[TBL] [Abstract][Full Text] [Related]
19. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
